Thomas Smith, M.D., serves as the Executive Vice President and Chief Medical Officer at Collegium Pharmaceutical Inc., a specialty pharmaceutical company focused on developing and commercializing innovative treatments for pain management. Dr. Smith brings a wealth of experience and expertise to his role, having spent over two decades in the pharmaceutical and healthcare industries. He holds a Doctor of Medicine degree and has a strong background in clinical development, medical affairs, and strategic leadership. Prior to joining Collegium Pharmaceutical, Dr. Smith held several key positions at leading pharmaceutical companies, where he played a pivotal role in the development and commercialization of novel therapies. His notable achievements include leading the successful launch of several pain management products and contributing to the design and execution of numerous clinical trials. Dr. Smith's deep understanding of the pain management landscape and his commitment to improving patient outcomes have been instrumental in driving Collegium's mission to provide innovative solutions for patients suffering from chronic pain. As the Executive Vice President and Chief Medical Officer at Collegium Pharmaceutical, Dr. Smith is responsible for overseeing the company's medical affairs, clinical development, and pharmacovigilance strategies. He plays a critical role in ensuring that Collegium's products meet the highest standards of safety and efficacy, while also working closely with healthcare professionals and key opinion leaders to advance the field of pain management. Dr. Smith's leadership and vision have been essential in guiding Collegium's growth and success, and his contributions continue to shape the company's future as a leader in the development of innovative pain treatments.